Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Troglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Liposarcoma 1

Interventions

Cyclophosphamide 3141 Cisplatin 3134 Carboplatin 2915 Paclitaxel 2659 Radiotherapy 2632 Gemcitabine 2524 pembrolizumab 2314 Docetaxel 2148 Bevacizumab 2112 Fluorouracil 1808 Capecitabine 1767 Oxaliplatin 1694 Dexamethasone 1577 Nivolumab 1511 Doxorubicin 1475 Rituximab 1446 Etoposide 1337 Magnetic Resonance Spectroscopy 1245 Irinotecan 1227 Leucovorin 1205 Cytarabine 1119 Pemetrexed 1053 Drug Therapy 1048 fludarabine 1023 Vincristine 955 Prednisone 925 Cetuximab 913 Lenalidomide 911 Specimen Handling 905 Filgrastim 894

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003058 2017-02-13

Troglitazone in Treating Patients With Liposarcoma

Dana-Farber Cancer Institute

Phase 2 Completed

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡